NKTR-255 in combination with durvalumab following chemoradiation was well-tolerated in patients with non–small cell lung ...
TipRanks on MSN6h
ANGLE plc Advances Cancer Treatment with Dual AnalysisANGLE plc (GB:AGL) has released an update. ANGLE plc’s recent study highlights the potential of dual CTC-DNA and ctDNA analysis in enhancing ...
It comes as new analysis by Asthma and Lung UK found lung diseases were responsible for one in eight emergency hospital ...
Treatment options for prostate cancer vary depending on the ... often dismissing their symptoms or feeling embarrassed to ...
Dizal has submitted sunvozertinib’s new drug application (NDA) to the US Food and Drug Administration (FDA) aiming to secure approval for treating locally advanced or metastatic non-small cell lung ...
More people are getting cancer in their 20s, 30s, and 40s, and surviving, thanks to rapid advancement in care. Many will have ...
Since 2009, Pennsylvania’s Veterans Treatment Courts have been assisting veterans who are charged with crimes and are ...
Axicabtagene ciloleucel, known by the brand name Yescarta, has been accepted for treating adults with two types of blood cancer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback